|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
EBSCO_ocn957558066 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
160831s2017 nyu of 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d IDEBK
|d N$T
|d YDX
|d OCLCF
|d TEFOD
|d OCLCO
|d OCLCQ
|d OCLCA
|d AGLDB
|d SNK
|d DKU
|d AUW
|d INTCL
|d MHW
|d BTN
|d IGB
|d D6H
|d VTS
|d AU@
|d OCLCO
|d G3B
|d OCLCO
|d OCLCA
|d S8J
|d S9I
|d STF
|d GWM
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 960999940
|a 961202198
|
020 |
|
|
|a 9780826166678
|q (electronic bk.)
|
020 |
|
|
|a 0826166679
|q (electronic bk.)
|
020 |
|
|
|z 9780826166661
|
020 |
|
|
|z 0826166660
|
035 |
|
|
|a (OCoLC)957558066
|z (OCoLC)960999940
|z (OCoLC)961202198
|
037 |
|
|
|a 25FBAAB6-E27D-4513-BDA5-1E3FBBBE1945
|b OverDrive, Inc.
|n http://www.overdrive.com
|
050 |
|
4 |
|a RM301
|
060 |
1 |
4 |
|a WY 49
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.1
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Wirfs, Mari J.,
|e author.
|
245 |
1 |
4 |
|a The APRN's complete guide to prescribing drug therapy 2017 /
|c Mari J. Wirfs.
|
264 |
|
1 |
|a New York, NY :
|b Springer Publishing Company, LLC,
|c [2017]
|
300 |
|
|
|a 1 online resource (pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed September 12, 2016).
|
505 |
0 |
|
|a Cover; Title; Copyright; Contents; Reviewers; Abbreviations; Preface; Acknowledgments; Share The APRN's Complete Guide to Prescribing Drug Therapy 2017; Section I: Drug Therapy by Clinical Diagnosis; Acetaminophen Overdose; Antidote/Chelating Agent; Acne Rosacea; Topical Alpha-2 Agonist; Topical Antimicrobials; Oral Antimicrobials; Acne Vulgaris; Antibacterial Soaps; Topical Antimicrobials; Oral Antimicrobials; Topical Retinoids; Topical Retinoid/Antimicrobial Combinations; Oral Retinoid; Oral Contraceptives; Acromegaly; Growth Hormone Receptor Antagonist; Actinic Keratosis
|
505 |
8 |
|
|a Alcohol Dependence/Alcohol Withdrawal SyndromeAlcohol Withdrawal Syndrome; Abstinence Therapy; Aversion Therapy; Allergic Reaction: General; Parenteral Antihistamine; Alzheimer's Disease; Nutritional Supplement; Reversible Anticholinesterase Inhibitors (RAIs); N-Methyl-D-Aspartate (NMDA) Receptor Antagonist; N-Methyl-D-Aspartate (NMDA) Receptor Antagonist/Acetylcholin-Esterase Inhibitor Combination; Ergot Alkaloid (Dopamine Agonist); Amebiasis; Amebiasis (Intestinal); Amebiasis (Extraintestinal); Amebic Liver Abscess; Anti-Infectives; Amenorrhea: Secondary; Anaphylaxis
|
505 |
8 |
|
|a Anaphylaxis Emergency Treatment KitsAnemia of Chronic Kidney Disease (CKD) and Chronic Renal Failure (CRF); Erythropoiesis Stimulating Agents (ESAs); Erythropoietin Human, Recombinant; Anemia: Folic Acid Deficiency; Anemia: Iron Deficiency; Iron Preparations; Anemia: Megaloblastic/Anemia: Pernicious; Angina Pectoris: Stable; Calcium Antagonists; Beta-Blockers; Nitrates; Non-Nitrate Peripheral Vasodilator; Nitrate/Peripheral Vasodilator Combination; Non-Nitrate Anti-Anginal; Anorexia/Cachexia; Appetite Stimulants; Anthrax (Bacillus Anthracis)
|
505 |
8 |
|
|a Postexposure Prophylaxis of Inhalational Anthrax and Treatment of Inhaled and Cutaneous Anthrax InfectionImmune Globulin; Treatment of Inhalational, GI, and Oropharyngeal Anthrax; Anxiety Disorder: Generalized (GAD)/Anxiety Disorder: Social (SAD); 1st Generation Antihistamine; Azaspirones; Benzodiazepines; Tricyclic Antidepressants (TCAs); Phenothiazines; Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs); Combination Agents; Aphthous Stomatitis (Mouth Ulcer, Canker Sore); Anti-Inflammatory Agents; Topical Anesthetics
|
505 |
8 |
|
|a Debriding Agent/CleanserAnti-Infectives; Aspergillosis (Scedosporium Apiospermum, Fusarium SPP.); Invasive Infection; Asthma; Leukotriene Receptor Antagonists (LRAs); IGE Blocker (IGG1K Monoclonal Antibody); Inhaled Anticholinergics; Inhaled Corticosteroids; Inhaled Mast Cell Stabilizers (Prophylaxis); Inhaled Beta Agonists (Bronchodilators); Inhaled Racepinephrine (Bronchodilator); Inhaled Long-Acting Anticholinergic; Inhaled Anticholinergic/Beta Agonist; Inhaled Beta Agonist (Long-Acting) (LABA); Corticosteroid/Inhaled Long-Acting Beta Agonist (LABA); Oral Beta2-Agonists (Bronchodilators)
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Drugs
|v Handbooks, manuals, etc.
|
650 |
1 |
2 |
|a Drug Therapy
|x nursing
|
650 |
2 |
2 |
|a Advanced Practice Nursing
|x methods
|
650 |
|
6 |
|a Médicaments
|v Guides, manuels, etc.
|
650 |
|
7 |
|a MEDICAL / Pharmacology
|2 bisacsh
|
650 |
|
7 |
|a Drugs
|2 fast
|
655 |
|
2 |
|a Handbook
|
655 |
|
7 |
|a handbooks.
|2 aat
|
655 |
|
7 |
|a Handbooks and manuals
|2 fast
|
655 |
|
7 |
|a Handbooks and manuals.
|2 lcgft
|
655 |
|
7 |
|a Guides et manuels.
|2 rvmgf
|
776 |
0 |
8 |
|i Print version:
|a Wirfs, Mari J.
|t APRN's complete guide to prescribing drug therapy 2017.
|d New York, NY : Springer Publishing Company, LLC, [2017]
|z 9780826166661
|w (DLC) 2016013691
|w (OCoLC)945566006
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1343276
|z Texto completo
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis35711230
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1343276
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 12973735
|
994 |
|
|
|a 92
|b IZTAP
|